Cargando…
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605530/ https://www.ncbi.nlm.nih.gov/pubmed/33055421 http://dx.doi.org/10.1172/jci.insight.144624 |
_version_ | 1783604320409747456 |
---|---|
author | Pender, Michael P. Csurhes, Peter A. Smith, Corey Douglas, Nanette L. Neller, Michelle A. Matthews, Katherine K. Beagley, Leone Rehan, Sweera Crooks, Pauline Hopkins, Tracey J. Blum, Stefan Green, Kerryn A. Ioannides, Zara A. Swayne, Andrew Aftab, Blake T. Hooper, Kaye D. Burrows, Scott R. Thompson, Kate M. Coulthard, Alan Khanna, Rajiv |
author_facet | Pender, Michael P. Csurhes, Peter A. Smith, Corey Douglas, Nanette L. Neller, Michelle A. Matthews, Katherine K. Beagley, Leone Rehan, Sweera Crooks, Pauline Hopkins, Tracey J. Blum, Stefan Green, Kerryn A. Ioannides, Zara A. Swayne, Andrew Aftab, Blake T. Hooper, Kaye D. Burrows, Scott R. Thompson, Kate M. Coulthard, Alan Khanna, Rajiv |
author_sort | Pender, Michael P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7605530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society for Clinical Investigation |
record_format | MEDLINE/PubMed |
spelling | pubmed-76055302020-11-04 Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis Pender, Michael P. Csurhes, Peter A. Smith, Corey Douglas, Nanette L. Neller, Michelle A. Matthews, Katherine K. Beagley, Leone Rehan, Sweera Crooks, Pauline Hopkins, Tracey J. Blum, Stefan Green, Kerryn A. Ioannides, Zara A. Swayne, Andrew Aftab, Blake T. Hooper, Kaye D. Burrows, Scott R. Thompson, Kate M. Coulthard, Alan Khanna, Rajiv JCI Insight Corrigendum American Society for Clinical Investigation 2020-10-15 /pmc/articles/PMC7605530/ /pubmed/33055421 http://dx.doi.org/10.1172/jci.insight.144624 Text en © 2020 sclerosis et al. http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Corrigendum Pender, Michael P. Csurhes, Peter A. Smith, Corey Douglas, Nanette L. Neller, Michelle A. Matthews, Katherine K. Beagley, Leone Rehan, Sweera Crooks, Pauline Hopkins, Tracey J. Blum, Stefan Green, Kerryn A. Ioannides, Zara A. Swayne, Andrew Aftab, Blake T. Hooper, Kaye D. Burrows, Scott R. Thompson, Kate M. Coulthard, Alan Khanna, Rajiv Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title | Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title_full | Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title_fullStr | Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title_full_unstemmed | Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title_short | Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis |
title_sort | epstein-barr virus–specific t cell therapy for progressive multiple sclerosis |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605530/ https://www.ncbi.nlm.nih.gov/pubmed/33055421 http://dx.doi.org/10.1172/jci.insight.144624 |
work_keys_str_mv | AT pendermichaelp epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT csurhespetera epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT smithcorey epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT douglasnanettel epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT nellermichellea epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT matthewskatherinek epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT beagleyleone epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT rehansweera epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT crookspauline epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT hopkinstraceyj epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT blumstefan epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT greenkerryna epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT ioannideszaraa epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT swayneandrew epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT aftabblaket epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT hooperkayed epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT burrowsscottr epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT thompsonkatem epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT coulthardalan epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis AT khannarajiv epsteinbarrvirusspecifictcelltherapyforprogressivemultiplesclerosis |